| News
Switzerland Innovation Park Basel Area opens site on Novartis Campus
17.08.2020
Switzerland Innovation Park Basel Area has opened a new location at the Novartis Campus. From here, the innovation park’s operator, Basel Area Business & Innovation, is to support startups and companies from the fields of digital health and personalized medicine.

Startup atmosphere in the Switzerland Innovation Park Basel Area on the Novartis Campus (img: Adriano A. Biondo)
Over the coming years, Novartis is to increasingly open up its campus based in Basel to companies active in the area of life sciences. Basel Area Business & Innovation is the first major external organization to benefit from this approach. In this context, a press release explains how the investment and innovation promotion agency is able to open a new location for Switzerland Innovation Park Basel Area, which it operates, at the Novartis Campus.
From here, Basel Area Business & Innovation will now support startups and established firms from the fields of digital health and personalized medicine across an area of 580 square meters. “The objective is to establish a closeness between startups and the scientists from Novartis and thereby foster new forms of exchange, collaboration and innovation”, the press release states. A total of eight startups have already set up shop at the Novartis Campus, while the DayOne Accelerator is also based there. “For us, the proximity to Novartis is of huge interest because we provide software in the field of neurology that can be used both in everyday clinical practice and also in the testing of new medicines”, comments Sebastian Mathias Keller in the press release, Co-Founder and CEO of Rekonas Medical, which has moved into the new office space.
The Switzerland Innovation Park Basel Area therefore now has a fourth site. Previously, it was represented in Allschwil in the canton of Basel-Landschaft, Basel and Jura. “The opening of the site on the Novartis Campus is a godsend for us,” comments Christof Klöpper, CEO of Basel Area Business & Innovation, before adding: “We see it as a vote of confidence from Novartis and as recognition of the quality of the Switzerland Innovation Park Basel Area”.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
BLKB supporting startups in Basel region
Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...
Read MoreBioVersys receives funding in the fight against tuberculosis
The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...
Read MoreBiosynex takes up residence in Delémont
The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has...
Read MoreNovartis Campus opening further
Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...
Read Moredocdok.health increases safety of coronavirus vaccinations
The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...
Read MoreHemex attracts Swiss investors
A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...
Read More